Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Managers’ transactions

Posted on: 03 Nov 17

BioPorto A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.


1 Details of the person discharging managerial responsibilities/person closely associated


a) Name Thomas Magnussen
2 Reason for the notification  
a) Position/status Chairman of the Board
b) Initial notification/Amendment Initial notification
3 Details of the issuer  
a) Name BioPorto A/S
b) LEI 5299004SWFL5JAN4W830
4 Details of the transaction(s)  
a) Description of the financial instrument, type of instrument
Identification code
ISIN: DK0011048619
b) Nature of the transaction Subscription in connection with a private placement
c) Price(s) and volume(s) Price: DKK 3.20, Volume: 312,500
d) Aggregated information n/a
e) Date of the transaction 2017-11-03
f) Place of the transaction Outside a trading venue


For further information please contact:

Peter Mørch Eriksen, CEO

Gry Husby Larsen, Investor relations

Tel.: 45 29 00 00, e-mail


Last updated on: 06/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.